argenx SE (ARGX.BR)
ARGX.BR on Brussels Stock Exchange
122.30EUR
1:45pm BST
122.30EUR
1:45pm BST
Change (% chg)
€-0.90 (-0.73%)
€-0.90 (-0.73%)
Prev Close
€123.20
€123.20
Open
€122.20
€122.20
Day's High
€122.70
€122.70
Day's Low
€120.50
€120.50
Volume
30,273
30,273
Avg. Vol
121,529
121,529
52-wk High
€125.80
€125.80
52-wk Low
€54.30
€54.30
About
argenx SE, formerly arGEN X BV, is the Netherlands-based biopharmaceutical company. It creates and develops a pipeline of differentiated antibody therapeutics using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of antibody therapeutics focused... (more)
Overall
| Beta: | -- |
| Market Cap(Mil.): | €583.54 |
| Shares Outstanding(Mil.): | 26.89 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ARGX.BR | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 69.29 | 32.55 |
| EPS (TTM): | -1.07 | -- | -- |
| ROI: | -19.69 | 8.90 | 13.82 |
| ROE: | -19.69 | 10.04 | 15.24 |
Estimates